Contact
Privacy
DMCA
Robuta
https://alcoholstudies.rutgers.edu/access-to-substance-use-treatment-during-pregnancy/
Access to Substance Use Treatment During Pregnancy | Center of Alcohol & Substance Use Studies
substance use treatment
access to
during pregnancy
https://pmc.ncbi.nlm.nih.gov/articles/PMC7207058/
Psychotropic Treatment During Pregnancy: Research Synthesis and Clinical Care Principles - PMC
Background: Psychiatric illnesses are common in women of childbearing age. The perinatal period is a particularly high-risk time for depression, bipolar, and...
treatment during pregnancy
research synthesis
clinical care
psychotropic
https://umu.diva-portal.org/smash/record.jsf?pid=diva2%3A1395148
Anti-TNF treatment during pregnancy and birth outcomes : Apopulation-based study from Denmark,...
treatment during pregnancy
https://www.cochrane.org/evidence/CD006753_psychosocial-interventions-women-enrolled-alcohol-treatment-during-pregnancy
Psychosocial interventions for women enrolled in alcohol treatment during pregnancy | Cochrane
treatment during pregnancy
psychosocial interventions
for women
enrolled
https://umu.diva-portal.org/smash/record.jsf?pid=diva2:1258659
Tnf inhibitor treatment during pregnancy and risk of preterm birth
treatment during pregnancy
tnf
inhibitor
risk
preterm
https://tobias-lib.uni-tuebingen.de/xmlui/handle/10900/123074?show=full
Olanzapine treatment during pregnancy and breastfeeding:a chance for women with psychotic illness?
treatment during pregnancy
https://pubmed.ncbi.nlm.nih.gov/20739726/
Dilemmas in treatment of women with familial hypercholesterolaemia during pregnancy
Familial hypercholesterolaemia (FH) is a co-dominant monogenic disorder of lipoprotein metabolism, characterised by severely elevated levels of low-density...
in treatment
of women
dilemmas
familial
hypercholesterolaemia
https://www.unsw.edu.au/research/ndarc/resources/managing-hepatitis-c-treatment-during-pregnancy
Australian healthcare provider perspectives on managing hepatitis C treatment during pregnancy:...
hepatitis c treatment
australian healthcare
provider
perspectives